Home/ Stocks/ LXRX

Lexicon Pharmaceuticals, Inc.

LXRX XNAS

$2.00 +0.28 (+16.67%) ▲ 15-min delayed

Open

$1.69

High

$2.00

Low

$1.64

Volume

7.02M

Market Cap

$888.39M

About Lexicon Pharmaceuticals, Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 81 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	$21.10M	$-1,043,000	$0.00
FY 2025	$49.80M	$-50,341,000	$-0.14
Q3 2025	$14.18M	$-12,769,000	$-0.04
Q2 2025	$28.87M	$3.25M	$0.01

Earnings & Analyst Ratings

Next Earnings: Tue, Aug 4, 2026

Calendar →

Related Market News

No specific coverage for LXRX yet. Check out our latest market news or earnings calendar.

Get LXRX Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Lexicon Pharmaceuticals, Inc..

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.